drugset / Trial / NCT06219733
Vactosertib and Imatinib Combination in Patients with Advanced Desmoid Tumor/aggressive Fibromatosis (DT/AF)
RandomizedParallel-groupOpen-labelTreatment
Summary
Vactosertib and imatinib combination in patients with advanced desmoid tumor/aggressive fibromatosis (DT/AF) compared with imatinib monotherapy
Timeline
- Start
- 2021-06-01
- Primary completion
- 2022-05-23
- Completion
- 2022-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Imatinib | Small molecule | 400 mg | Oral |
| Subject | Vactosertib | Small molecule | 200 mg | Oral |